Clinical Trials
3 trialsNCT02446600 2026-06-03
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT03278717 2022-09-27
ICON9
University College, London
Phase 3 Unknown
NCT00532194 2015-09-23
ICON6
Medical Research Council
Phase 3 Unknown